A Snp Marker of Breast and Ovarian Cancer Risk
The invention provides methods for predicting an increased risk or probability of developing breast or ovarian cancer in a patient based upon the patient's KRAS-Variant and BRCA status.
WEIDHAAS JOANNE B [US]
Type of Offer:
« More Biotech Patents